The Legionella testing industry is poised for significant growth, with revenues projected to reach US$742.5 million by 2034, driven by increasing concerns about public health and safety due to Legionnaires’ disease outbreaks. The Asia Pacific region is expected to lead this growth, fueled by rising healthcare infrastructure and awareness campaigns.